Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Pierconti

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Cancer Cytopathology|March 28, 2023
p53 expression in cytology samples may represent a marker of early-stage cancerFederica Policardo, Pietro Tralongo, Damiano Arciuolo, et al.
Clinical Genetics|January 17, 2022
Prevalence of bladder cancer in Costello syndrome: New insights to drive clinical decision-makingChiara Leoni, Filomena Valentina Paradiso, Nazario Foschi, et al.
Diagnostics (Basel, Switzerland)|October 14, 2023
The Role of Checkpoint Inhibitor Expression Directly on Exfoliated Cells from Bladder Cancer: A Narrative ReviewLuca Di Gianfrancesco, Alessandro Crestani, Antonio Amodeo, et al.
La Radiologia Medica|June 29, 2026
Diagnostic performance of bpMRI versus mpMRI and AI-assisted bpMRI in prostate cancer detection: a multi-reader studyLuca Russo, Silvia Bottazzi, Luca D'Erme, et al.
Virchows Archiv : an International Journal of Pathology|November 8, 2023
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapyAnna Caliò, Stefano Marletta, Giulio Settanni, et al.
Cancers|December 30, 2020
Metabolic Reprogramming by Malat1 Depletion in Prostate CancerSimona Nanni, Aurora Aiello, Chiara Salis, et al.
Pathologica|March 14, 2024
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinomaMatteo Brunelli, Stefano Gobbo, Giorgio Malpeli, et al.
Cancer Cell International|February 5, 2024
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancerValeria Pecci, Fabiola Troisi, Aurora Aiello, et al.
Pathology|February 29, 2020
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targetsAnna Caliò, Matteo Brunelli, Diego Segala, et al.
Virchows Archiv : an International Journal of Pathology|February 3, 2026
Diagnostic practice and awareness of SDH- and FH-deficient renal cell carcinoma: results from an Italian Study Group of uropathology (GIUP) surveyGiuseppe Nicolò Fanelli, Anna Caliò, Stefano Marletta, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Cancer Cytopathology|March 28, 2023
p53 expression in cytology samples may represent a marker of early-stage cancerFederica Policardo, Pietro Tralongo, Damiano Arciuolo, et al.
Clinical Genetics|January 17, 2022
Prevalence of bladder cancer in Costello syndrome: New insights to drive clinical decision-makingChiara Leoni, Filomena Valentina Paradiso, Nazario Foschi, et al.
Diagnostics (Basel, Switzerland)|October 14, 2023
The Role of Checkpoint Inhibitor Expression Directly on Exfoliated Cells from Bladder Cancer: A Narrative ReviewLuca Di Gianfrancesco, Alessandro Crestani, Antonio Amodeo, et al.
La Radiologia Medica|June 29, 2026
Diagnostic performance of bpMRI versus mpMRI and AI-assisted bpMRI in prostate cancer detection: a multi-reader studyLuca Russo, Silvia Bottazzi, Luca D'Erme, et al.
Virchows Archiv : an International Journal of Pathology|November 8, 2023
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapyAnna Caliò, Stefano Marletta, Giulio Settanni, et al.
Cancers|December 30, 2020
Metabolic Reprogramming by Malat1 Depletion in Prostate CancerSimona Nanni, Aurora Aiello, Chiara Salis, et al.
Pathologica|March 14, 2024
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinomaMatteo Brunelli, Stefano Gobbo, Giorgio Malpeli, et al.
Cancer Cell International|February 5, 2024
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancerValeria Pecci, Fabiola Troisi, Aurora Aiello, et al.
Pathology|February 29, 2020
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targetsAnna Caliò, Matteo Brunelli, Diego Segala, et al.
Virchows Archiv : an International Journal of Pathology|February 3, 2026
Diagnostic practice and awareness of SDH- and FH-deficient renal cell carcinoma: results from an Italian Study Group of uropathology (GIUP) surveyGiuseppe Nicolò Fanelli, Anna Caliò, Stefano Marletta, et al.
Pageof 12